Colgate Palmolive Co (CL): who owns it and who trades it
As of Nov 16, 2026, CL insiders reported 20 open-market sales worth $64.2M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Noel R. Wallace (CEO), with $36M. 7 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Colgate Palmolive
From the latest filingsOverall: more selling than buying. Insiders and Congress mostly sold. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CL
2,009 funds and institutions reported CL shares worth $62.7B at the end of Q2 2026, about 86% of the company. The largest holder is BlackRock, Inc. with 8.8%.
Funds and institutions (13F) 86%Everyone else 14%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 69.92M | 8.77% | $6.4B | -4% |
| Vanguard Capital Management LLC | 52.25M | 6.55% | $4.8B | +0% |
| State Street Corp | 47.02M | 5.90% | $4.3B | -1% |
| T. Rowe Price Associates | 27.91M | 3.50% | $2.6B | -17% |
| Vanguard Portfolio Management LLC | 24.02M | 3.01% | $2.2B | +1% |
| Geode Capital Management, LLC | 23.14M | 2.90% | $2.1B | +1% |
| Morgan Stanley | 22.07M | 2.77% | $2B | +6% |
| First Eagle Investment Management, LLC | 16.41M | 2.06% | $1.5B | +102% |
| Bank of New York Mellon Corp | 13.53M | 1.70% | $1.2B | +8% |
| Deutsche Bank Ag\ | 11.75M | 1.47% | $1.1B | -1% |
| Norges Bank | 9.69M | 1.22% | $888M | – |
| Acadian Asset Management LLC | 9.10M | 1.14% | $834M | +15% |
| FMR LLC (Fidelity) | 8.98M | 1.13% | $824M | -0% |
| Goldman Sachs Group Inc | 8.57M | 1.08% | $786M | -10% |
| Northern Trust Corp | 8.47M | 1.06% | $777M | -2% |
| Invesco Ltd. | 8.33M | 1.04% | $763M | -0% |
| State Farm Mutual Automobile Insurance Co | 6.73M | 0.84% | $617M | No change |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 6.47M | 0.81% | $593M | -5% |
| Amundi | 6.22M | 0.78% | $570M | +20% |
| Bank of America Corp | 6.19M | 0.78% | $567M | -7% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CL insiders reported $0 of open-market purchases and $64.2M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Gregory Malcolm | Vice president | Sale | 4,100 | $97.97 | $402K | Form 4 |
| Nov 5, 2026 | Lorrie M Norrington | Director | Sale | 4,170 | $99.31 | $414K | Form 4 |
| Nov 5, 2026 | Noel R. Wallace | CEO | Sale | 20,000 | $100.26 | $2M | Form 4 |
| Nov 4, 2026 | John Hazlin | Chief Growth Officer | Sale | 23,376 | $99.15 | $2.3M | Form 4 |
| Nov 4, 2026 | Panagiotis Tsourapas | COO | Sale | 19,938 | $98.74 | $2M | Form 4 |
| Aug 24, 2026 | Panagiotis Tsourapas | COO | Sale | 10,000 | $92.05 | $920K | Form 4 |
| Aug 6, 2026 | John T Cahill | Director | Sale | 4,170 | $93.37 | $389K | Form 4 |
| Aug 5, 2026 | Noel R. Wallace | CEO | Sale | 161,021 | $92.52 | $14.9M | Form 4 |
| Aug 4, 2026 | Noel R. Wallace | CEO | Sale | 161,021 | $91.92 | $14.8M | Form 4 |
| May 15, 2026 | Gregory Malcolm | Vice president | Sale | 2,300 | $88.44 | $203K | Form 4 |
| May 7, 2026 | Sally Massey | Chief People Officer | Sale | 8,599 | $87.41 | $752K | Form 4 |
| Feb 12, 2026 | Panagiotis Tsourapas | COO | Sale | 15,000 | $97.81 | $1.5M | Form 4 |
| Feb 11, 2026 | Panagiotis Tsourapas | COO | Sale | 35,000 | $94.61 | $3.3M | Form 4 |
| Feb 10, 2026 | John Hazlin | Chief Growth Officer | Sale | 20,989 | $94.25 | $2M | Form 4 |
| Feb 6, 2026 | Gregory Malcolm | Vice president | Sale | 12,747 | $94.91 | $1.2M | Form 4 |
| Feb 5, 2026 | Sally Massey | Chief Human Resources Of | Sale | 15,851 | $95.03 | $1.5M | Form 4 |
| Feb 4, 2026 | Stanley J Sutula III | CFO | Sale | 97,843 | $94.27 | $9.2M | Form 4 |
| Feb 4, 2026 | Jennifer Daniels | CLO and Secretary | Sale | 22,000 | $94.34 | $2.1M | Form 4 |
| Feb 4, 2026 | Noel R. Wallace | CEO | Sale | 45,568 | $93.91 | $4.3M | Form 4 |
| Nov 21, 2025 | Sally Massey | Chief Human Resources Of | Sale | 1,237 | $80.89 | $100K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Noel R. Wallace | Chairman, President & CEO, Director | – | $36M | Nov 5, 2026 |
| Stanley J Sutula III | Chief Financial Officer | – | $9.2M | Feb 4, 2026 |
| Panagiotis Tsourapas | COO, Eur., APac, Afr Eur, Skin | – | $7.7M | Nov 4, 2026 |
| John Hazlin | Chief Growth Officer | – | $4.3M | Nov 4, 2026 |
| Sally Massey | Chief Human Resources Officer | – | $2.4M | May 7, 2026 |
| Jennifer Daniels | CLO and Secretary | – | $2.1M | Feb 4, 2026 |
| Gregory Malcolm | EVP and Controller | – | $1.8M | Nov 10, 2026 |
| Lorrie M Norrington | Director | – | $414K | Nov 5, 2026 |
| John T Cahill | Director | – | $389K | Aug 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CL short interest
Low short interest. 2.3% of CL shares are sold short: about 1 share in 43. Over the last 12 reports the number of shares short went down 7%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 18.54M CL shares were sold short, 2.3% of the shares outstanding, up 6.5% from the report before. At the average daily volume of 4.95M shares, buying them all back would take about 3.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 18.54M | 2.33% | +7% | 4.95M | 3.8 |
| Oct 15, 2026 | 17.41M | 2.19% | -28% | 4.93M | 3.5 |
| Sep 30, 2026 | 24.04M | 3.02% | +31% | 6.00M | 4.0 |
| Sep 15, 2026 | 18.40M | 2.31% | +7% | 4.61M | 4.0 |
| Aug 31, 2026 | 17.17M | 2.15% | -2% | 4.12M | 4.2 |
| Aug 14, 2026 | 17.56M | 2.20% | -1% | 4.34M | 4.0 |
| Jul 31, 2026 | 17.77M | 2.23% | +6% | 4.63M | 3.8 |
| Jul 15, 2026 | 16.72M | 2.10% | -5% | 4.33M | 3.9 |
| Jun 30, 2026 | 17.53M | 2.20% | -15% | 6.12M | 2.9 |
| Jun 15, 2026 | 20.53M | 2.57% | -3% | 5.43M | 3.8 |
| May 29, 2026 | 21.14M | 2.64% | +7% | 5.09M | 4.2 |
| May 15, 2026 | 19.84M | 2.48% | +15% | 5.39M | 3.7 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded CL
Since Nov 17, 2024, 7 members of Congress reported 3 purchases and 12 sales of CL. The latest was a sale by Kevin Hern on Sep 2, 2026, reported Sep 25, 2026.
Purchases 3Sales 12
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Kevin Hern (R-OK) | Partial sale | $1K–$15K | Joint | Sep 25, 2026 | Report |
| Aug 31, 2026 | Kevin Hern (R-OK) | Sale | $1K–$15K | Self | Sep 25, 2026 | Report |
| Aug 27, 2026 | Kevin Hern (R-OK) | Partial sale | $1K–$15K | Self | Sep 25, 2026 | Report |
| Aug 19, 2026 | Kevin Hern (R-OK) | Sale | $1K–$15K | Joint | Sep 1, 2026 | Report |
| Oct 6, 2025 | Rick Larsen (D-WA) | Sale | $1K–$15K | Self | Oct 16, 2025 | Report |
| Sep 25, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | Oct 7, 2025 | Report |
| Sep 23, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | Aug 5, 2026 | Report |
| Sep 23, 2025 | Julie Johnson (D-TX) | Purchase | $1K–$15K | Joint | Aug 5, 2026 | Report |
| Sep 11, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Oct 22, 2025 | Report |
| Sep 10, 2025 | Tim Moore (R-NC) | Sale | $1K–$15K | Self | Oct 10, 2025 | Report |
| Aug 13, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| Jul 31, 2025 | Shelley Moore Capito (R-WV) | Sale | $1K–$15K | Spouse | Aug 4, 2025 | Report |
| Jul 11, 2025 | Ritchie Torres (D-NY) | Sale | $1K–$15K | Self | Aug 20, 2025 | Report |
| Jun 24, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jun 17, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Colgate Palmolive company events
Colgate Palmolive filed 8 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, job cuts). The latest was on Oct 30, 2026.
- Oct 30, 2026ResultsReleased financial results. Filing
- Jul 31, 2026ResultsReleased financial results. Filing
- May 13, 2026VoteReported shareholder vote results. Filing
- May 1, 2026Job cutsAnnounced job cuts or other exit costs. Filing
- Apr 9, 2026LeadershipJennifer M. Daniels, who has served as Chief Legal Officer and Secretary of Colgate-Palmolive Company since 2014, has communicated to the Company her intention to retire from the Company in 2026. Filing
- Mar 17, 2026AnnouncementAs part of the previously announced Strategic Growth and Productivity Program, to further optimize and leverage the operating scale and drive growth within the Europe and Africa/Eurasia regions, effective for the quarter ending March 31, 2026, Colgate-Palmolive Company has realigned its reportable… Filing
- Mar 12, 2026LeadershipThe Board of Directors of Colgate-Palmolive Company elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company, to the Colgate-Palmolive Board, effective March 15, 2026. Filing
- Jan 30, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Colgate Palmolive financials
Famous investors that hold CL
7 of the 50 well-known investors we track reported holding CL in their latest 13F filing. The largest position is Jim Simons's, worth $140M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 1.64M | $140M | 0.2% | +86% |
| Israel Englander · Millennium Management | Q3 2026 | 664,778 | $56.7M | 0.0% | -48% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 510,582 | $43.6M | 0.0% | -89% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 100,653 | $8.6M | 0.0% | +64% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 66,553 | $5.7M | 0.0% | New |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 47,550 | $4.1M | 0.0% | -38% |
| Jeremy Grantham · GMO | Q3 2026 | 31,342 | $2.7M | 0.0% | -43% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Colgate Palmolive Co (CL) stock
Who owns the most CL stock?
The largest reported owner of Colgate Palmolive Co (CL) is BlackRock, Inc., with 8.8% of the company. In total, 2,009 funds and institutions reported holding CL at the end of Q2 2026, together about 86% of the shares. See the largest owners.
Are CL insiders buying or selling?
In the last 12 months, CL insiders reported no open-market purchases and 20 sales worth $64.2M. The latest trade was on Nov 10, 2026. See every trade.
What is the short interest in CL?
As of Oct 30, 2026, 18.54M CL shares were sold short, 2.3% of the shares outstanding, up 6.5% from the report before. At the average daily volume of 4.95M shares, buying them all back would take about 3.8 trading days (days to cover). See the history.
Have members of Congress traded CL?
Yes. 7 members of Congress reported 3 purchases and 12 sales of CL since Nov 17, 2024. The latest was reported on Sep 25, 2026. See the trades.
Which famous investors hold CL?
7 of the 50 well-known investors we track reported CL in their latest 13F filing, including Jim Simons, Israel Englander, Ken Griffin. The largest position is worth $140M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.